Ensysce Biosciences Inc (ENSC)

Ensysce Biosciences Inc (ENSC) is a Biotechnology company in the Healthcare sector listed on the NASDAQ.

As of Oct 23, 2026: market cap $7.8M; returns 1 day -7.9%, 1 week -9.2%, 1 year -77.7%.

Ensysce Biosciences Inc. is a clinical-stage biopharmaceutical company focused on developing innovative solutions for severe pain relief while aiming to reduce opioid misuse, abuse, and overdose. Their primary focus is on developing safer opioid painkillers through advanced drug formulations.

Groups ENSC belongs to

• Biotechnology
• Clinical Stage Biopharma
• Pain Management
• Clinical Stage
• Healthcare
• Biopharmaceutical
• Pharmaceuticals
• Digestive Health

ENSC financial model: income statement, cash flow and balance sheet